About
Ellen Scordino focuses on patent and trade secret litigation and client counseling in the pharmaceuticals, biologics, diagnostics, biofuels, and medical device industries but has also represented clients in a wide range of other patent and general commercial matters in courts across the country and in arbitrations. She has particular expertise with Hatch-Waxman and BPCIA litigations and has led trial teams in obtaining favorable judgments and settlements in district courts and inter partes review proceedings. Scordino has also worked extensively with clients to create patent and litigation strategies mindful of regulatory issues and the FDA. She has litigated and counseled clients on matters involving blockbuster drugs, biologics and biosimilars, orphan drugs, PCR technologies, recombinant DNA technologies, medical devices, cannabis, biofuels, and chemistry (including food and consumer good additives).
Practice areas
Office
Expertise
Education
- J.D., Fordham University School of Law
- B.S., Trinity College